chr4:85475150:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr4:86,396,303-86,923,821 |
| hg38 | chr4:85,475,150-86,002,668 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | squamous cell carcinoma | NA | BeFree | Detail | |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| 0.005 | colorectal carcinoma | Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects aga... | BeFree | 26294215 | Detail |
| <0.001 | Colorectal Neoplasms | NA | BeFree | Detail | |
| <0.001 | adenoid cystic carcinoma | NA | BeFree | Detail | |
| <0.001 | Ependymoma | NA | BeFree | Detail | |
| <0.001 | Esophageal Neoplasms | p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an inc... | BeFree | 24820515 | Detail |
| <0.001 | Fanconi anemia | NA | BeFree | Detail | |
| <0.001 | gastritis | NA | BeFree | Detail | |
| <0.001 | Gastrointestinal Neoplasms | NA | BeFree | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| <0.001 | Focal glomerulosclerosis | NA | BeFree | Detail | |
| <0.001 | Graft-vs-Host Disease | NA | BeFree | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| <0.001 | hepatitis C | NA | BeFree | Detail | |
| <0.001 | Hunger | NA | BeFree | Detail | |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| 0.001 | leukemia | NA | BeFree | Detail | |
| 0.002 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | lymphoid leukemia | NA | BeFree | Detail | |
| 0.002 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.003 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| <0.001 | myeloid leukemia | NA | BeFree | Detail | |
| <0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myeloid, Chronic-Phase | NA | BeFree | Detail | |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukoplakia | NA | BeFree | Detail | |
| <0.001 | liver cirrhosis | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.004 | lymphoma | NA | BeFree | Detail | |
| <0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
| <0.001 | Lymphoproliferative Disorders | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of stomach | Our meta-analysis indicates that p73 G4A might not have a major effect on risk o... | BeFree | 25400764 | Detail |
| <0.001 | medulloblastoma | NA | BeFree | Detail | |
| 0.002 | melanoma | NA | BeFree | Detail | |
| 0.001 | meningioma | NA | BeFree | Detail | |
| <0.001 | mitral valve stenosis | NA | BeFree | Detail | |
| <0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
| 0.001 | multiple myeloma | NA | BeFree | Detail | |
| <0.001 | multiple sclerosis | NA | BeFree | Detail | |
| <0.001 | Nasal Polyps | NA | BeFree | Detail | |
| 0.004 | Neoplasm Metastasis | We constructed oncolytic viruses armed with an inhibitor of deacetylation and/or... | BeFree | 25071017 | Detail |
| 0.004 | Neoplasm Metastasis | Restin suppressed epithelial-mesenchymal transition and tumor metastasis in brea... | BeFree | 25972084 | Detail |
| 0.009 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Melanocytic nevus | NA | BeFree | Detail | |
| <0.001 | oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | osteosarcoma | NA | BeFree | Detail | |
| 0.004 | ovarian carcinoma | NA | BeFree | Detail | |
| <0.001 | Parathyroid Neoplasms | NA | BeFree | Detail | |
| <0.001 | Precancerous Conditions | NA | BeFree | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| <0.001 | retinoblastoma | NA | BeFree | Detail | |
| <0.001 | Stomach Neoplasms | NA | BeFree | Detail | |
| <0.001 | Thyroid Neoplasm | NA | BeFree | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| <0.001 | Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
| <0.001 | diffuse large B-cell lymphoma | NA | BeFree | Detail | |
| <0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
| <0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
| <0.001 | Lymphoma, T-Cell, Cutaneous | NA | BeFree | Detail | |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
| <0.001 | Oral Cavity Carcinoma | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| <0.001 | esophageal carcinoma | p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an inc... | BeFree | 24820515 | Detail |
| <0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of oropharynx | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
| <0.001 | Autoimmune thyroid disease | NA | BeFree | Detail | |
| 0.002 | Tumor Progression | In parallel, although the tumor-suppressor p53 acts as the first barrier against... | BeFree | 26032560 | Detail |
| <0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
| 0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
| <0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Testicular embryonal carcinoma | NA | BeFree | Detail | |
| 0.004 | Malignant neoplasm of lung | Treatment of cells with curcumin induced both p53 and the related protein p73 in... | BeFree | 25910231 | Detail |
| <0.001 | parathyroid adenoma | NA | BeFree | Detail | |
| <0.001 | inflammatory breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Ovarian epithelial cancer stage III | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Metastatic melanoma | Eradication of metastatic melanoma through cooperative expression of RNA-based H... | BeFree | 25071017 | Detail |
| <0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of esophagus | p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased risk ... | BeFree | 24820515 | Detail |
| <0.001 | Squamous cell carcinoma of esophagus | The oncogene and tumor suppressor gene protein expression was related to the pro... | BeFree | 25622532 | Detail |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of oropharynx | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Segmental glomerulosclerosis | NA | BeFree | Detail | |
| <0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
| <0.001 | anaplastic oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | Human papilloma virus infection | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Disseminated Malignant Neoplasm | We constructed oncolytic viruses armed with an inhibitor of deacetylation and/or... | BeFree | 25071017 | Detail |
| 0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
| 0.002 | Hematologic Neoplasms | NA | BeFree | Detail | |
| 0.120 | Electrocardiogram: P-R interval | NA | GWASCAT | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of esophagus | p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an inc... | BeFree | 24820515 | Detail |
| <0.001 | Recurrent Carcinoma | NA | BeFree | Detail | |
| 0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of skin | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of mouth | NA | BeFree | Detail | |
| <0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
| 0.014 | Carcinogenesis | Thus, the impact of p73 on tumorigenesis depends on a subtle balance between tum... | BeFree | 24742294 | Detail |
| 0.014 | Carcinogenesis | The transcription factor p73 belongs to the p53-family and regulates tumorigenes... | BeFree | 25514460 | Detail |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | NA | BeFree | Detail | |
| 0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.005 | breast carcinoma | Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation... | BeFree | 25071010 | Detail |
| 0.005 | breast carcinoma | Restin suppressed epithelial-mesenchymal transition and tumor metastasis in brea... | BeFree | 25972084 | Detail |
| 0.004 | Carcinoma of lung | Treatment of cells with curcumin induced both p53 and the related protein p73 in... | BeFree | 25910231 | Detail |
| 0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | NA | BeFree | Detail | |
| 0.002 | stomach carcinoma | Our meta-analysis indicates that p73 G4A might not have a major effect on risk o... | BeFree | 25400764 | Detail |
| 0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
| 0.008 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
| <0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
| 0.002 | Drug-Induced Liver Injury | NA | GAD | Detail | |
| <0.001 | Borderline ovarian tumour | NA | BeFree | Detail | |
| <0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
| <0.001 | ovarian neoplasm | NA | BeFree | Detail | |
| <0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| 0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
| <0.001 | differentiated thyroid gland carcinoma | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| <0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
| <0.001 | Autism Spectrum Disorders | NA | BeFree | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| 0.004 | colorectal cancer | Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects aga... | BeFree | 26294215 | Detail |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
| <0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.004 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD | Detail | |
| 0.005 | liver carcinoma | Piper betle leaf extracts induced human hepatocellular carcinoma Hep3B cell deat... | BeFree | 25371988 | Detail |
| <0.001 | Oropharyngeal Carcinoma | NA | BeFree | Detail | |
| <0.001 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | NA | BeFree | Detail | |
| <0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| <0.001 | GASTRIC CANCER, INTESTINAL | NA | BeFree | Detail | |
| <0.001 | myelodysplastic syndrome | NA | BeFree | Detail | |
| <0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
| <0.001 | Triple Negative Breast Neoplasms | Together, these results indicate that activation of a RASAL2/ARHGAP24/RAC1 modul... | BeFree | 25384218 | Detail |
| <0.001 | Allergic disposition | NA | BeFree | Detail | |
| 0.001 | adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | adenoma | NA | BeFree | Detail | |
| <0.001 | Alzheimer's disease | NA | BeFree | Detail | |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| <0.001 | atherosclerosis | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
| <0.001 | Blast Phase | NA | BeFree | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of breast | Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation... | BeFree | 25071010 | Detail |
| 0.005 | Malignant neoplasm of breast | Restin suppressed epithelial-mesenchymal transition and tumor metastasis in brea... | BeFree | 25972084 | Detail |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| <0.001 | Bronchogenic Carcinoma | NA | BeFree | Detail | |
| <0.001 | Merkel cell carcinoma | NA | BeFree | Detail | |
| 0.002 | Non-small cell lung carcinoma | Association between a p73 gene polymorphism and genetic susceptibility to non-sm... | BeFree | 25556480 | Detail |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Canc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an increased risk of esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our meta-analysis indicates that p73 G4A might not have a major effect on risk of gastric cancer. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We constructed oncolytic viruses armed with an inhibitor of deacetylation and/or p73 to specifically... | DisGeNET | Detail |
| Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells thro... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an increased risk of esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In parallel, although the tumor-suppressor p53 acts as the first barrier against tumor transformatio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Treatment of cells with curcumin induced both p53 and the related protein p73 in head and neck and l... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased risk of ESCC. | DisGeNET | Detail |
| The oncogene and tumor suppressor gene protein expression was related to the prognostic factor, and ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We constructed oncolytic viruses armed with an inhibitor of deacetylation and/or p73 to specifically... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an increased risk of esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Thus, the impact of p73 on tumorigenesis depends on a subtle balance between tumor-promoting and -su... | DisGeNET | Detail |
| The transcription factor p73 belongs to the p53-family and regulates tumorigenesis via its two N-ter... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast can... | DisGeNET | Detail |
| Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells thro... | DisGeNET | Detail |
| Treatment of cells with curcumin induced both p53 and the related protein p73 in head and neck and l... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our meta-analysis indicates that p73 G4A might not have a major effect on risk of gastric cancer. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Canc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Piper betle leaf extracts induced human hepatocellular carcinoma Hep3B cell death via MAPKs regulati... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Together, these results indicate that activation of a RASAL2/ARHGAP24/RAC1 module contributes to TNB... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast can... | DisGeNET | Detail |
| Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells thro... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between a p73 gene polymorphism and genetic susceptibility to non-small cell lung cancer... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg38
- Position
- chr4:85,475,150-86,002,668
- Variant Type
- snv
Genome browser